Evidence map›Paper›PMID 36924781›Full record

SynthesisThe Lancet. Child & adolescent health2023

Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis.

Kenneth S Gunasekera, Olivier Marcy, Johanna Muñoz, Elisa Lopez-Varela, Moorine P Sekadde, Molly F Franke, Maryline Bonnet, Shakil Ahmed, Farhana Amanullah, Aliya Anwar and 40 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in The Lancet. Child & adolescent health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Asymptomatic Tuberculosis in Children With Household Exposure to Mycobacterium tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors.

Kenneth S GunasekeraDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. Electronic address: kenneth.gunasekera@yale.edu.
Olivier MarcyInserm UMR1219, Institut de Recherche pour le Développement EMR 271, GHiGS, University of Bordeaux, Bordeaux, France.
Johanna MuñozJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Elisa Lopez-VarelaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Moorine P SekaddeNational Tuberculosis and Leprosy Program, Kampala, Uganda.
Molly F FrankeDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Maryline BonnetUniversity of Montpellier, TransVIHMI, Institut de Recherche pour le Développement, Inserm, Montpellier, France; Epicentre, Mbarara, Uganda.
Shakil AhmedDepartment of Paediatrics, Dhaka Medical College Hospital, Dhaka, Bangladesh.
Farhana AmanullahIndus Hospital & Health Network, Karachi, Pakistan; The Aga Khan University Hospital, Karachi, Pakistan.
Aliya AnwarIndus Hospital & Health Network, Karachi, Pakistan.
Orvalho AugustoCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Rafaela Baroni AurilioInstituto de Puericultura e Pediatria Martagao Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Sayera BanuProgramme on Emerging Infections, Infectious Disease Division, icddr,b, Dhaka, Bangladesh.
Iraj BatoolIndus Hospital & Health Network, Karachi, Pakistan.
Annemieke BrandsGlobal Tuberculosis Programme, WHO, Geneva, Switzerland.
Kevin P CainUS Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lucía Carratalá-CastroISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Maxine CawsDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; Birat Nepal Medical Trust, Lazmipat, Kathmandu, Nepal.
Eleanor S ClickUS Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lisa M CranmerDepartment of Pediatrics, Emory School of Medicine, Atlanta, GA, USA; Department of Epidemiology, Emory Rollins School of Public Health, Atlanta, GA, USA; Children's Healthcare of Atlanta, Atlanta, GA, USA.
Alberto L García-BasteiroISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Barcelona, Spain.
Anneke C HesselingDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Julie HuynhOxford University Clinical Research Unit, Centre for Tropical Diseases, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Senjuti KabirProgramme on Emerging Infections, Infectious Disease Division, icddr,b, Dhaka, Bangladesh.
Leonid LeccaDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA; Socios En Salud Surcursal Perú, Lima, Perú.
Anna MandalakasGlobal TB Program, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA; Clinical Infectious Disease Group, German Center for Infectious Research, Clinical TB Unit, Research Center Borstel, Borstel, Germany.
Farai MavhungaGlobal Tuberculosis Programme, WHO, Geneva, Switzerland.
Aye Aye MyintDepartment of Paediatrics, University of Medicine, Mandalay, Myanmar.
Kyaw MyoDepartment of Paediatrics, University of Medicine, Magway, Myanmar.
Dorah NampijjaDepartment of Paediatrics, Mbarara University of Science and Technology, Mbarara, Uganda.
Mark P NicolDivision of Infection and Immunity, Department of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Patrick OrikirizaEpicentre, Mbarara, Uganda; Department of Microbiology, Division of Basic Medical Sciences, School of Medicine, University of Global Health Equity, Kigali, Rwanda.
Megan PalmerDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Clemax Couto Sant'AnnaFaculty of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Sara Ahmed SiddiquiDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA; Indus Hospital & Health Network, Karachi, Pakistan.
Jonathan P SmithDepartment of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Rinn SongDepartment of Pediatrics, Harvard Medical School, Boston, MA, USA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Nguyen Thuy Thuong ThuongOxford University Clinical Research Unit, Centre for Tropical Diseases, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Vibol UngUniversity of Health Sciences, Phnom Penh, Cambodia; National Pediatric Hospital, Phnom Penh, Cambodia.
Marieke M van der ZalmDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Sabine VerkuijlGlobal Tuberculosis Programme, WHO, Geneva, Switzerland.
Kerri VineyGlobal Tuberculosis Programme, WHO, Geneva, Switzerland; School of Public Health, University of Sydney, Sydney, NSW, Australia.
Elisabetta G WaltersDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa; Directorate of Integrated Laboratory Medicine, Institute of Human Genetics, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.
Joshua L WarrenDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
Heather J ZarDepartment of Paediatrics and Child Health, Red Cross Children's Hospital, and SA-MRC Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.
Ben J MaraisThe Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Stephen M GrahamDepartment of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia.
Thomas P A DebrayJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Ted CohenDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
James A SeddonDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa; Department of Infectious Diseases, Imperial College London, London, UK.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Neel Rajnikant Gandhi · 2022 to 2026
$5.8M
Predicting and monitoring variations in the effects of vaccines against RSVR01AI137093 · NIAID · YALE UNIVERSITY · PI Virginia E Pitzer, Daniel Martin Weinberger · 2018 to 2026
$3.4M
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemicsR01AI147854 · NIAID · YALE UNIVERSITY · PI COHEN, THEODORE H, SALOMON, JOSHUA A · 2020 to 2023
$3.1M
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment MonitoringR01AI137527 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI MANDALAKAS, ANNA M · 2019 to 2022
$2.7M
Diagnosis of Tuberculosis in HIV-infected children & development of microbiologicR01HD058971 · NICHD · UNIVERSITY OF CAPE TOWN · PI ZAR, HEATHER JOY · 2008 to 2012
$2.2M
Siyakhula: Growing HIV/TB Research Knowledge for Growing Healthy Kids in EswatiniD43TW011547 · FIC · BAYLOR COLLEGE OF MEDICINE · PI MANDALAKAS, ANNA M · 2021 to 2025
$1.7M
The role of antibodies in infant TB preventionK23AI143479 · NIAID · EMORY UNIVERSITY · PI CRANMER, LISA M · 2019 to 2023
$950k
Improving TB Diagnosis in Children with and without HIV in KenyaK23HD072802 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SONG, RINN · 2012 to 2016
$672k
The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African childrenK43TW011028 · FIC · STELLENBOSCH UNIVERSITY · PI VAN DER ZALM, MARIEKE MARGREET · 2020 to 2024
$647k
Spatial and Decision Analytic Models for Addressing Challenges in Pediatric Tuberculosis Control and CareF30HD105440 · NICHD · YALE UNIVERSITY · PI GUNASEKERA, KENNETH SURANGA · 2021 to 2022
$83k
FIC NIH HHS D43 TW011547FIC NIH HHS K43 TW011028Medical Research Council MR/R007942/1NCATS NIH HHS UL1 TR001863NIAID NIH HHS K23 AI143479NIAID NIH HHS P30 AI168386NIAID NIH HHS R01 AI137093NIAID NIH HHS R01 AI137527NIAID NIH HHS R01 AI147854NICHD NIH HHS F30 HD105440NICHD NIH HHS K23 HD072802NICHD NIH HHS R01 HD058971NIGMS NIH HHS T32 GM007205PEPFARWorld Health Organization 001
6 · The paper itself

Abstract

backgroundMany children with pulmonary tuberculosis remain undiagnosed and untreated with related high morbidity and mortality. Recent advances in childhood tuberculosis algorithm development have incorporated prediction modelling, but studies so far have been small and localised, with limited generalisability. We aimed to evaluate the performance of currently used diagnostic algorithms and to use prediction modelling to develop evidence-based algorithms to assist in tuberculosis treatment decision making for children presenting to primary health-care centres.

methodsFor this meta-analysis, we identified individual participant data from a WHO public call for data on the management of tuberculosis in children and adolescents and referral from childhood tuberculosis experts. We included studies that prospectively recruited consecutive participants younger than 10 years attending health-care centres in countries with a high tuberculosis incidence for clinical evaluation of pulmonary tuberculosis. We collated individual participant data including clinical, bacteriological, and radiological information and a standardised reference classification of pulmonary tuberculosis. Using this dataset, we first retrospectively evaluated the performance of several existing treatment-decision algorithms. We then used the data to develop two multivariable prediction models that included features used in clinical evaluation of pulmonary tuberculosis-one with chest x-ray features and one without-and we investigated each model's generalisability using internal-external cross-validation. The parameter coefficient estimates of the two models were scaled into two scoring systems to classify tuberculosis with a prespecified sensitivity target. The two scoring systems were used to develop two pragmatic, treatment-decision algorithms for use in primary health-care settings.

findingsOf 4718 children from 13 studies from 12 countries, 1811 (38·4%) were classified as having pulmonary tuberculosis: 541 (29·9%) bacteriologically confirmed and 1270 (70·1%) unconfirmed. Existing treatment-decision algorithms had highly variable diagnostic performance. The scoring system derived from the prediction model that included clinical features and features from chest x-ray had a combined sensitivity of 0·86 [95% CI 0·68-0·94] and specificity of 0·37 [0·15-0·66] against a composite reference standard. The scoring system derived from the model that included only clinical features had a combined sensitivity of 0·84 [95% CI 0·66-0·93] and specificity of 0·30 [0·13-0·56] against a composite reference standard. The scoring system from each model was placed after triage steps, including assessment of illness acuity and risk of poor tuberculosis-related outcomes, to develop treatment-decision algorithms.

interpretationWe adopted an evidence-based approach to develop pragmatic algorithms to guide tuberculosis treatment decisions in children, irrespective of the resources locally available. This approach will empower health workers in primary health-care settings with high tuberculosis incidence and limited resources to initiate tuberculosis treatment in children to improve access to care and reduce tuberculosis-related mortality. These algorithms have been included in the operational handbook accompanying the latest WHO guidelines on the management of tuberculosis in children and adolescents. Future prospective evaluation of algorithms, including those developed in this work, is necessary to investigate clinical performance.

fundingWHO, US National Institutes of Health.

Indexed as

TuberculosisTuberculosis, PulmonaryAdolescentAlgorithmsChildHumansRetrospective StudiesTriageUnited States

Identifiers

PMID36924781
PMCPMC10127218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.